Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2011

Authors

  • Deepika Mahajan National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children’s Hospital at Westmead, Sydney, New South Wales
  • Jane Cook Office of Product Review, Therapeutic Goods Administration, Canberra, Australian Capital Territory
  • Peter McIntyre National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children’s Hospital at Westmead, Sydney, New South Wales
  • Kristine Macartney National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children’s Hospital at Westmead, Sydney, New South Wales
  • Rob Menzies National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children’s Hospital at Westmead, Sydney, New South Wales

DOI:

https://doi.org/10.33321/cdi.2012.36.7

Keywords:

AEFI, surveillance, immunisation, vaccine safety

Abstract


This report summarises national passive surveillance data reported to the Therapeutic Goods Administration (TGA) to 31 August 2011 for adverse events following immunisation (AEFI) reported for children aged less than 7 years who received vaccines between 1 January and 30 June 2011. The report includes all vaccines administered to children in this age group with a focus on the vaccines included in the funded National Immunisation Program (NIP) schedule.

Downloads

Download data is not yet available.

References

National Health and Medical Research Council. The Australian Immunisation Handbook. 9th edn. Canberra: Australian Government Department of Health and Ageing, 2008.

Victorian State Government, Department of Health. National Immunisation Program Schedule. [online] Accessed on 1 December 2010. Available from: http:// health.vic.gov.au/immunisation/fact-sheets/factsheets/ schedule_victoria

Government of South Australia Department of Health. New vaccine schedule from 1 March 2008. Sharp and to the point 2008;(23):1. [serial online]. Accessed on 30 August 2010. Available from: http://www.dh.sa.gov. au/pehs/Immunisation/0803-sharp-point-news.pdf

Queensland Health. National Immunisation Program Queensland schedule. [online]. Accessed on 1 September 2010. Available from: http://www.health.sa.gov.au/ immunisationcalculator/QldMar2008.pdf

Victorian Department of Human Services. Changed immunisation schedule from 1 March 2008. Immunisation newsletter 2008;(32):1. [serial online]. Accessed on 1 September 2010. Available from: http://www.health. vic.gov.au/__data/assets/pdf_file/0015/130083/ Immunisation-newsletter-issue-32.pdf

Centers for Disease Control and Prevention. Continued shortage of Haemophilus influenzae type b (Hib) conjugate vaccines and potential implications for Hib surveillance—United States, 2008. MMWR Morb Mortal Wkly Rep 2008;57(46):1252–1255.

Lawrence G, Menzies R, Burgess M, McIntyre P, Wood N, Boyd I, et al. Surveillance of adverse events following immunisation: Australia, 2000–2002. Commun Dis Intell 2003;27(3):307–323.

Mahajan D, Menzies R, Cook J, Macartney K, McIntyre P. Supplementary report: surveillance of adverse events following immunisation among children aged < 7 years in Australia, 1 January to 30 June 2010. Commun Dis Intell 2011;35(1):18–25.

Mahajan D, Menzies R, Roomiani I, Lawrence GL. Supplementary report: surveillance of adverse events following immunisation among children aged < 7 years in Australia, 1 January to 30 June 2009. Commun Dis Intell 2010;34(1):49–53.

Mahajan D, Roomiani I, Gold M, Lawrence G, McIntyre P, Menzies R. Annual report: surveillance of adverse events following immunisation in Australia, 2009. Commun Dis Intell 2010;34(3):259–276.

Menzies R, Mahajan D, Gold MS, Roomiani I, McIntyre P, Lawrence G. Annual report: surveillance of adverse events following immunisation in Australia, 2008. Commun Dis Intell 2009;33(4):365–381.

Blyth CC, Currie AJ, Wiertsema SP, Conway N, Kirkham LA, Fuery A, et al. Trivalent influenza vaccine and febrile adverse events in Australia, 2010: clinical features and potential mechanisms. Vaccine 2011;29(32):5107–5113.

Rennels MB. Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines. Seminars in Pediatr Infect Dis J 2003;14(3):196–198.

Liese JG, Stojanov S, Zink TH, et al. Safety and immunogenicity of Biken acellular pertussis vaccine in combination with diphtheria and tetanus toxoid as a fifth dose at four to six years of age. Pediatr Infect Dis J 2001;20(10):981–988.

NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2009: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2011;35(2):61–131.

Hull B, Dey A, Mahajan D, Menzies, RI, McIntyre PB. Immunisation coverage annual report, 2009. Commun Dis Intell 2011;35(2):132–148.

Downloads

Published

01/03/12

How to Cite

Mahajan, Deepika, Jane Cook, Peter McIntyre, Kristine Macartney, and Rob Menzies. 2012. “Supplementary Report: Surveillance of Adverse Events Following Immunisation Among Children Aged Less Than Seven Years in Australia, 1 January to 30 June 2011”. Communicable Diseases Intelligence 36 (March):114-19. https://doi.org/10.33321/cdi.2012.36.7.

Issue

Vol. 36 (2012)

Section

Surveillance summary

Categories

License

Copyright (c) 2012 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

<< < 1 2 3 4 5 6 7 8 9 > >>